Showing 41,641 - 41,660 results of 71,344 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 10 ((mg decrease) OR (mean decrease)) ))', query time: 1.52s Refine Results
  1. 41641
  2. 41642

    Diagnostic and prognostic role of platelets in patients with sepsis and septic shock by Tobias Schupp (13980761)

    Published 2022
    “…Following platelet decline, recovery was observed from day 5 to day 10 (mean increase 7.5%). However, platelet recovery was not found to be associated with 30-day all-cause mortality (HR = 1.072; 95% CI 0.567–2.026; <i>p</i> = .832). …”
  3. 41643
  4. 41644

    Efficacy of UVC irradiation on non-colored BxPC-3, BxPC-3-Ab488 and BxPC-3-GFP in vitro. by Yukihiko Hiroshima (568068)

    Published 2014
    “…Compared to non-colored BxPC-3 cells, the number of BxPC-3-Ab488 and BxPC-3-GFP cells decreased significantly due to UVC irradiation with 25 and 50 J/m<sup>2</sup>. …”
  5. 41645
  6. 41646
  7. 41647

    Relative gene expression of <i>IL1Β</i> in controls and vitiligo patients. by Naresh C. Laddha (111354)

    Published 2014
    “…ANOVA's trend test confirmed a significant decrease in the mean ΔCp values for patients (<i>p</i> = 0.035), as compared to controls (<i>p</i> = 0.154). …”
  8. 41648

    <i>mPINC</i> expression declines during lactogenic hormone induced differentiation of HC11 cells. by Amy N. Shore (148122)

    Published 2012
    “…Data are presented as mean ± SEM (n = 3). (A) qPCR shows <i>mPINC1.0</i> and <i>mPINC1.6</i> expression decreases following 24 and 72 hrs of hormone treatment. …”
  9. 41649
  10. 41650
  11. 41651

    Table_1_Effect of Abdominal Circumference on the Irradiated Bowel Volume in Pelvic Radiotherapy for Rectal Cancer Patients: Implications for the Radiotherapy-Related Intestinal Tox... by Gang Wang (36685)

    Published 2022
    “…Weight, height, AC, and body mass index (BMI) were used as the research objects, and the irradiated bowel volume at different dose levels (V10, V20, V30, V40, V50) was selected as the outcome variable. …”
  12. 41652

    Table_1_ARV-825 Demonstrates Antitumor Activity in Gastric Cancer via MYC-Targets and G2M-Checkpoint Signaling Pathways.xls by Xinmei Liao (11574571)

    Published 2021
    “…ARV-825, consisting of a BRD4 inhibitor conjugated with a cereblon ligand using proteolysis-targeting chimera (PROTAC) technology, was proven to decrease the tumor growth effectively and continuously. …”
  13. 41653

    <i>ADF</i> with <i>th</i> variation. by Takayuki Niizato (162226)

    Published 2012
    “…(D) A graph of the mean , or , for 50 times simulations from <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0035615#pone-0035615-g007" target="_blank">Figure 7A</a>. …”
  14. 41654

    Supplementary Figure S1 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain M... by James S. Wilmott (15008931)

    Published 2025
    “…A) Gene expression of related oncogenic signalling pathways between treatment timepoints and site, B) Estimated mean difference of proteins and pathways between biopsy categories (95% confidence interval for the estimated mean difference is depicted as a segment), C) Multiplex immunohistochemical staining for key intracellular signalling proteins, D) Changes in immune intratumoral immune cell densities between treatment timepoints and site, E and F) Multiplex immunohistochemical staining depicted marked decrease in immune cell densities EDT in PT4 (steroid treated). …”
  15. 41655
  16. 41656
  17. 41657
  18. 41658
  19. 41659
  20. 41660